In an AI/ML-centric world, data is invaluable—akin to gold or diamonds, whether rough or polished. Yet, the critical aspect of data licensing, distinct from intellectual property (IP), is often overlooked in traditional life sciences agreements.
Join us for an engaging session where we will delve into real-world examples and discuss the essential considerations when dealing with modern technologies. Hear from leading experts in data and AI/ML, alongside the lawyers who help navigate the complex and uncharted territory of data ownership, from transformation and model training to the generation of synthetic data. This is an opportunity to gain valuable insights and stay ahead in the evolving landscape of life sciences.
